clinafloxacin has been researched along with Neutropenia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Armitage, HT; Kerr, KG; McWhinney, PH | 1 |
Brodfuehrer, JI; Eiseman, I; Randinitis, EJ; Vassos, AB | 1 |
Brennscheidt, U; Cornely, O; Figuera, A; Glauser, MP; Grigg, A; Keyserling, C; Tack, K; Trostmann, U; Welling, L | 1 |
2 trial(s) available for clinafloxacin and Neutropenia
Article | Year |
---|---|
Pharmacokinetics of clinafloxacin after single and multiple doses.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Infective Agents; Biological Availability; Female; Fluoroquinolones; Humans; Injections, Intravenous; Male; Middle Aged; Neutropenia | 2001 |
Clinafloxacin monotherapy (CI-960) versus ceftazidime plus amikacin for empirical treatment of febrile neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Ceftazidime; Cephalosporins; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fever; Fluoroquinolones; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Teicoplanin; Treatment Outcome; Vancomycin | 2002 |
1 other study(ies) available for clinafloxacin and Neutropenia
Article | Year |
---|---|
Activity of quinolones against viridans group streptococci isolated from blood cultures of patients with haematological malignancy.
Topics: Adult; Anti-Infective Agents; Bacteremia; Ciprofloxacin; Fleroxacin; Fluoroquinolones; Hematologic Neoplasms; Humans; Naphthyridines; Neutropenia; Risk Factors; Streptococcal Infections; Streptococcus | 1999 |